Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study

In patients with multiple myeloma (MM), SARS-CoV-2 infection has been associated with a severe clinical course and high mortality rates due to the concomitant disease- and treatment-related immunosuppression. Specific antiviral treatment involves viral replication control with monoclonal antibodies...

Descripción completa

Detalles Bibliográficos
Autores principales: Spiliopoulou, Vassiliki, Ntanasis-Stathopoulos, Ioannis, Malandrakis, Panagiotis, Gavriatopoulou, Maria, Theodorakakou, Foteini, Fotiou, Despina, Migkou, Magdalini, Roussou, Maria, Eleutherakis-Papaiakovou, Evangelos, Kastritis, Efstathios, Dimopoulos, Meletios A., Terpos, Evangelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054373/
https://www.ncbi.nlm.nih.gov/pubmed/36992413
http://dx.doi.org/10.3390/v15030704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054373/
https://www.ncbi.nlm.nih.gov/pubmed/36992413
http://dx.doi.org/10.3390/v15030704

Ejemplares similares